Send to a Friend Font Size: Increase Decrease

OrbiMed Advisors

OrbiMed Advisors's Portfolio

Last Updated on 5/16/11 @ 11:13am

Ticker	# of Shares	Price	Value
	73,114,592	$195.32	$14,280,742,110
	22,362,850	$195.32	$4,367,911,862
	17,233,668	$195.32	$3,366,080,034
	14,567,176	$195.32	$2,845,260,817
	9,033,726	$195.32	$1,764,467,363
	8,998,338	$195.32	$1,757,555,379
	8,322,140	$195.32	$1,625,480,385
	8,009,729	$195.32	$1,564,460,269
	7,619,135	$195.32	$1,488,169,449
View Additional Portfolio Information »

http://www.orbimed.com/OrbiMed is the world's largest healthcare-dedicated investment firm, with approximately $5 billion in assets under management. The firm was stated in 1989 with a vision to invest across the spectrum of healthcare companies: from private start-ups to large multinational companies.

Login to help us fill in information about this entity.

View Older Stories View More Recent Stories

Apr 9, 2026 05:35PM Form 144 Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Apr 8, 2026 08:14PM Form 144 Adicet Bio, Inc. Filed by: OrbiMed Advisors Israel II Ltd
Mar 31, 2026 09:58PM Form 144 Keros Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Mar 12, 2026 05:07PM Form SCHEDULE 13D/A Q32 Bio Inc. Filed by: ORBIMED ADVISORS LLC
Mar 4, 2026 09:12PM Form SCHEDULE 13D/A PMV Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Feb 17, 2026 06:33PM Form SCHEDULE 13G/A Vistagen Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 17, 2026 06:28PM Form SCHEDULE 13G InspireMD, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 17, 2026 06:24PM Form SCHEDULE 13G/A CytomX Therapeutics, Filed by: ORBIMED ADVISORS LLC
Feb 17, 2026 06:21PM Form SCHEDULE 13G CYBIN INC. Filed by: ORBIMED ADVISORS LLC
Feb 17, 2026 06:18PM Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 17, 2026 06:13PM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 17, 2026 06:06PM Form SCHEDULE 13G/A ADC Therapeutics SA Filed by: ORBIMED ADVISORS LLC
Feb 17, 2026 04:18PM Form 13F-HR ORBIMED ADVISORS LLC For: Dec 31
Feb 11, 2026 06:42PM Form SCHEDULE 13D/A MBX Biosciences, Inc. Filed by: ORBIMED ADVISORS LLC
Feb 4, 2026 07:39PM Form 4 Sionna Therapeutics, For: Feb 02 Filed by: ORBIMED ADVISORS LLC
Jan 27, 2026 08:39PM Form SCHEDULE 13D/A Corvus Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Dec 29, 2025 08:44PM Form 4 Sionna Therapeutics, For: Dec 24 Filed by: ORBIMED ADVISORS LLC
Dec 19, 2025 07:29PM Form 4 Sionna Therapeutics, For: Dec 17 Filed by: ORBIMED ADVISORS LLC
Nov 26, 2025 06:46PM Form 4 Sionna Therapeutics, For: Nov 24 Filed by: ORBIMED ADVISORS LLC
Nov 24, 2025 08:23PM Form 144 Sionna Therapeutics, Filed by: ORBIMED ADVISORS LLC
Nov 14, 2025 06:18PM Form SCHEDULE 13G/A RAPT Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 14, 2025 06:12PM Form SCHEDULE 13G/A InspireMD, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 14, 2025 06:08PM Form SCHEDULE 13G/A C4 Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Nov 14, 2025 06:05PM Form SCHEDULE 13G Vistagen Therapeutics, Filed by: ORBIMED ADVISORS LLC
Nov 14, 2025 04:16PM Form 13F-HR ORBIMED ADVISORS LLC For: Sep 30
Nov 5, 2025 04:13PM Form SCHEDULE 13D/A Terns Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Oct 27, 2025 05:19PM Form 4 PMV Pharmaceuticals, For: Oct 23 Filed by: ORBIMED ADVISORS LLC
Oct 27, 2025 05:12PM Form SCHEDULE 13D/A PMV Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Oct 23, 2025 06:39PM Form 144 PMV Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Oct 20, 2025 08:55PM Form 144 Disc Medicine, Inc. Filed by: ORBIMED ADVISORS LLC
Oct 20, 2025 08:52PM Form 144 Disc Medicine, Inc. Filed by: ORBIMED ADVISORS LLC
Oct 20, 2025 08:47PM Form 144 Disc Medicine, Inc. Filed by: ORBIMED ADVISORS LLC
Oct 10, 2025 08:06PM Form 4 Adicet Bio, Inc. For: Oct 08 Filed by: ORBIMED ADVISORS LLC
Oct 10, 2025 07:56PM Form SCHEDULE 13D/A Adicet Bio, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 30, 2025 07:07PM Form SCHEDULE 13D/A MBX Biosciences, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 12, 2025 05:09PM Form 4 PMV Pharmaceuticals, For: Sep 10 Filed by: ORBIMED ADVISORS LLC
Sep 10, 2025 06:51PM Form 144 PMV Pharmaceuticals, Filed by: ORBIMED ADVISORS LLC
Sep 2, 2025 09:53PM Form SCHEDULE 13D Shattuck Labs, Inc. Filed by: ORBIMED ADVISORS LLC
Sep 2, 2025 09:52PM Form 4 Shattuck Labs, Inc. For: Aug 25 Filed by: ORBIMED ADVISORS LLC
Sep 2, 2025 09:49PM Form 3 Shattuck Labs, Inc. For: Aug 25 Filed by: ORBIMED ADVISORS LLC
Aug 29, 2025 03:48PM Form N-PX ORBIMED ADVISORS LLC For: Jun 30
Aug 26, 2025 06:30AM Shattuck Labs closes $103 million private placement, adds board members
Aug 15, 2025 05:28PM Form SCHEDULE 13D/A Compass Therapeutics, Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 06:07PM Form SCHEDULE 13G CytomX Therapeutics, Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 06:03PM Form SCHEDULE 13G/A NeuroPace Inc Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 06:00PM Form SCHEDULE 13G/A Avalo Therapeutics, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 05:56PM Form SCHEDULE 13G/A Verastem, Inc. Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 05:53PM Form SCHEDULE 13G/A X4 Pharmaceuticals, Inc Filed by: ORBIMED ADVISORS LLC
Aug 14, 2025 04:40PM Form 13F-HR ORBIMED ADVISORS LLC For: Jun 30
Aug 13, 2025 07:44PM Form SCHEDULE 13D/A ArriVent BioPharma, Inc. Filed by: ORBIMED ADVISORS LLC

View More Recent Stories View Older Stories

Nasdaq		15000.33
	+57.68	(+0.39%)

S&P 500		4486.55
	+7.02	(+0.16%)

Market Snapshot

Free News Feed